Full Text
PIN8 COST EFFECTIVENESS OF THE MF59-ADJUVANTED INFLUENZA VACCINE IN FRANCE-THE “AT-RISK” ADULT POPULATION

Abstract

Authors

J Chambers K Tolley J Piercy S Wait

Back to Volume 10, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×